{"disease":{"id":"npdr-non-proliferative-diabetic-retinopathy","name":"npdr non proliferative diabetic retinopathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04636307","title":"Characterization of Retinal Disease Progression in Eyes With Non Proliferative Diabetic Retinopathy in Diabetes Type 2 Using Non-invasive Procedures (CHART)","phase":"","overall_status":"COMPLETED","enrollment_count":202,"lead_sponsor_name":"Association for Innovation and Biomedical Research on Light and Image","has_results":false},{"nct_id":"NCT03696810","title":"Characterization of Retinal Vascular Disease in Eyes With Mild to Moderate NPDR in Diabetes Type 2","phase":"NA","overall_status":"COMPLETED","enrollment_count":141,"lead_sponsor_name":"Association for Innovation and Biomedical Research on Light and Image","has_results":false},{"nct_id":"NCT04692688","title":"Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":103,"lead_sponsor_name":"Ocuphire Pharma, Inc.","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}